Banque Cantonale Vaudoise
GILD icon

Banque Cantonale Vaudoise’s Gilead Sciences GILD Stock Holding History

Banque Cantonale Vaudoise’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.22M Sell
55,170
-8,611
-14% -$1.21M 0.28% 61
2026
Q2 		$8.06K Sell
63,781
-11,997
-16% -$1.58M ﹤0.01% 236
2026
Q1 		$10.6M Buy
75,778
+4,814
+7% +$674K 0.4% 40
2025
Q4 		$8.71M Sell
70,964
-9,314
-12% -$1.13M 0.31% 51
2025
Q3 		$8.91M Sell
80,278
-16,310
-17% -$1.85M 0.33% 49
2025
Q2 		$10.7M Sell
96,588
-9,863
-9% -$1.05M 0.44% 35
2025
Q1 		$11.9M Buy
+106,451
New +$11M 0.53% 28
2024
Q3 		$12.4M Buy
148,490
+159
+0.1% +$12.1K 0.51% 32
2024
Q2 		$10.2M Buy
148,331
+20,465
+16% +$1.37M 0.4% 40
2024
Q1 		$9.36M Buy
127,866
+19,030
+17% +$1.46M 0.37% 47
2023
Q4 		$8.82M Buy
108,836
+5,733
+6% +$446K 0.38% 45
2023
Q3 		$7.73M Sell
103,103
-15,099
-13% -$1.16M 0.39% 47
2023
Q2 		$9.11M Sell
118,202
-26,530
-18% -$2.12M 0.42% 41
2023
Q1 		$12M Buy
144,732
+3,565
+3% +$295K 0.59% 27
2022
Q4 		$12.1M Buy
141,167
+14,784
+12% +$1.17M 0.63% 25
2022
Q3 		$7.8M Sell
126,383
-2,496
-2% -$157K 0.44% 39
2022
Q2 		$7.97M Sell
128,879
-7,431
-5% -$460K 0.41% 43
2022
Q1 		$8.1M Buy
136,310
+10,775
+9% +$689K 0.35% 54
2021
Q4 		$9.11M Buy
125,535
+3,469
+3% +$239K 0.36% 47
2021
Q3 		$8.53M Sell
122,066
-4,130
-3% -$290K 0.37% 46
2021
Q2 		$8.69M Sell
126,196
-4,750
-4% -$317K 0.39% 38
2021
Q1 		$8.46M Buy
130,946
+1,505
+1% +$97K 0.43% 36
2020
Q4 		$7.54M Buy
129,441
+7,006
+6% +$423K 0.42% 46
2020
Q3 		$7.73M Buy
122,435
+29,290
+31% +$2.03M 0.5% 38
2020
Q2 		$7.17M Sell
93,145
-7,198
-7% -$552K 0.52% 33
2020
Q1 		$7.5M Buy
100,343
+2,422
+2% +$167K 0.64% 29
2019
Q4 		$6.37M Buy
+97,921
New +$6.38M 0.44% 38

Other funds holding GILD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Banque Cantonale Vaudoise's GILD Position: Q3 2026 in Review

Banque Cantonale Vaudoise reduced its Gilead Sciences (GILD) stake by 14% in Q3 2026, selling an estimated $1.21M and leaving 55,170 shares worth $8.22M. The position accounts for 0.28% of the portfolio, ranked #61.

Banque Cantonale Vaudoise first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $12.4M in Q3 2024. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Banque Cantonale Vaudoise held 55,170 shares of Gilead Sciences worth $8.22M as of Q3 2026.
  • Banque Cantonale Vaudoise sold 8,611 Gilead Sciences shares in Q3 2026, an estimated $1.21M.
  • Gilead Sciences made up 0.28% of Banque Cantonale Vaudoise's portfolio in Q3 2026, its #61 holding.
  • Banque Cantonale Vaudoise first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Banque Cantonale Vaudoise's Gilead Sciences position peaked at $12.4M in Q3 2024.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2026, filed 12 Nov 2026.